(Q38989592)

8 September 2017

title

miR-339-5p regulates the p53 tumor-suppressor pathway by targeting MDM2. (English)

1 reference

8 September 2017

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24882579%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Anders Jacobsen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24882579%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Anders H. Lund

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24882579%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

author name string

N D Damas

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24882579%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

M Lees

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24882579%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

language of work or name

English

0 references

publication date

2 June 2014

1 reference

8 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24882579%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24882579%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

issue

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24882579%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

page(s)

1908-1918

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24882579%20AND%20SRC:MED&resulttype=core&format=json

Hallmarks of Cancer: The Next Generation

6 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.130

p53 in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.130

MicroRNAs: genomics, biogenesis, mechanism, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.130

MicroRNA functions in stress responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.130

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.130

MicroRNAs in the p53 network: micromanagement of tumour suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.130

p53-mediated activation of miRNA34 candidate tumor-suppressor genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.130

p53-independent upregulation of miR-34a during oncogene-induced senescence represses MYC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.130

MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.130

Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.130

miR-34a repression of SIRT1 regulates apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.130

miR-449 inhibits cell proliferation and is down-regulated in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.130

E2F1-inducible microRNA 449a/b suppresses cell proliferation and promotes apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.130

miR-449a targets HDAC-1 and induces growth arrest in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.130

p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.130

P53-induced microRNA-107 inhibits HIF-1 and tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.130

Mdm2-mediated ubiquitylation: p53 and beyond.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.130

MicroRNA-125b is a novel negative regulator of p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.130

Negative regulation of tumor suppressor p53 by microRNA miR-504

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.130

Negative regulation of the tumor suppressor p53 gene by microRNAs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.130

miR-30 regulates mitochondrial fission through targeting p53 and the dynamin-related protein-1 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.130

Downregulation of p53-inducible microRNAs 192, 194, and 215 impairs the p53/MDM2 autoregulatory loop in multiple myeloma development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.130

miR-605 joins p53 network to form a p53:miR-605:Mdm2 positive feedback loop in response to stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.130

Loss of microRNA-143/145 disturbs cellular growth and apoptosis of human epithelial cancers by impairing the MDM2-p53 feedback loop.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.130

miR-29 miRNAs activate p53 by targeting p85 alpha and CDC42.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.130

CPEB and two poly(A) polymerases control miR-122 stability and p53 mRNA translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.130

MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.130

Transcription-independent pro-apoptotic functions of p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.130

Modulation of microRNA processing by p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.130

Disruption of p53 in human cancer cells alters the responses to therapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.130

MDM2 is a negative regulator of p21WAF1/CIP1, independent of p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.130

MDM2 promotes p21waf1/cip1 proteasomal turnover independently of ubiquitylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.130

Triptolide is an inhibitor of RNA polymerase I and II-dependent transcription leading predominantly to down-regulation of short-lived mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.130

Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.130

The role of site accessibility in microRNA target recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.130

Intrinsic tumour suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.130

The Mdm2-p53 relationship evolves: Mdm2 swings both ways as an oncogene and a tumor suppressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.130

MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.130

The p53 orchestra: Mdm2 and Mdmx set the tone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.130

Mdm2 promotes genetic instability and transformation independent of p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.130

Opposing effects of Ras on p53: transcriptional activation of mdm2 and induction of p19ARF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.130

MDM2, MDMX and p53 in oncogenesis and cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.130

MiR-339-5p inhibits breast cancer cell migration and invasion in vitro and may be a potential biomarker for breast cancer prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.130

MiR-339-5p regulates the growth, colony formation and metastasis of colorectal cancer cells by targeting PRL-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.130

Fast and effective prediction of microRNA/target duplexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.130

Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.130

A model for the computer analysis of synchronous DNA distributions obtained by flow cytometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.130

31 March 2020

Identifiers

DOI

10.1038/ONC.2014.130

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24882579%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

6 June 2020

1040046633

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24882579%20AND%20SRC:MED&resulttype=core&format=json